Similar articles

• Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350.

  Raboisson P, de Kock H, Rosenquist A, Nilsson M, Salvador-Oden L, Lin TI, Roue N, Ivanov V, Wähling H, Wickström K, Hamelink E, Edlund M, Vrang L, Vendeville S, Van de Vreken W, McGowan D, Tahri A, Hu L, Boutton C, Lenz O, Delouvroy F, Pille G, Surleraux D, Wigerinck P, Samuelsson B, Simmen K. Raboisson P, et al. Bioorg Med Chem Lett. 2008 Sep 1;18(17):4853-8. doi: 10.1016/j.bmcl.2008.07.088. Epub 2008 Jul 24. Bioorg Med Chem Lett. 2008. PMID: 18678486
• Bismacrocyclic inhibitors of hepatitis C NS3/4a protease.

  McCauley JA, Rudd MT, Nguyen KT, McIntyre CJ, Romano JJ, Bush KJ, Varga SL, Ross CW 3rd, Carroll SS, DiMuzio J, Stahlhut MW, Olsen DB, Lyle TA, Vacca JP, Liverton NJ. McCauley JA, et al. Angew Chem Int Ed Engl. 2008;47(47):9104-7. doi: 10.1002/anie.200803298. Angew Chem Int Ed Engl. 2008. PMID: 18925594 No abstract available.
• Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.

  Massariol MJ, Zhao S, Marquis M, Thibeault D, White PW. Massariol MJ, et al. Biochem Biophys Res Commun. 2010 Jan 1;391(1):692-7. doi: 10.1016/j.bbrc.2009.11.122. Epub 2009 Nov 26. Biochem Biophys Res Commun. 2010. PMID: 19944069
• TMC-435, an NS3/4A protease inhibitor for the treatment of HCV infection.

  Tsantrizos YS. Tsantrizos YS. Curr Opin Investig Drugs. 2009 Aug;10(8):871-81. Curr Opin Investig Drugs. 2009. PMID: 19649931 Review.
• Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry.

  Pillaiyar T, Namasivayam V, Manickam M. Pillaiyar T, et al. Curr Med Chem. 2016;23(29):3404-3447. doi: 10.2174/0929867323666160510122525. Curr Med Chem. 2016. PMID: 27160539 Review.